AI Shows Promise for Intraoperative Lung Adenocarcinoma Assessment

• by Andrea Surnit

• May 29, 2026

Vaginal DNA Assay Shows Promise

A two-marker methylated DNA assay identified endometrial cancer with 96% sensitivity in self-collected vaginal fluid — but prospective validation is needed before it can reduce biopsies in routine care.

• by Kerri Miller

• May 8, 2026

• 14 min

Cancer Is Coming for Younger Adults — and the Field Isn’t Ready

The epidemiological tools built for midlife disease are straining to explain a generational shift

• by Kerri Miller

• April 7, 2026

• 3 min

Creation of a lipoprotein(a) model to forecast progression-free survival and severe adverse events in metastatic lung adenocarcinoma patients lacking driver genes and with PD-L1 TPS under 50%

• by Sicong Li, Yiyuan Cui, Yijing Yan, Hao Li, Yue Jin, Yufan Chen, Jingjie Yu, Li Feng

• April 24, 2026